Last edition
News about Global Pharma
US Pharma Import Tariffs May Hit Indian Pharma Companies
The proposed new tariff by the United States of America on pharma imports may affect Indian pharmaceutical majors. Shares of many pharmaceutical brands tumbled.
Global Pharma | 12/05/2025 | By Manvi | 1634
Agilent Launches First India Solution Center in Manesar to Drive Innovation and Growth
Agilent announced the opening of its first-ever India Solution Center at its LEED Platinum-certified office in Manesar, Haryana. Designed to provide integrated solutions, this strategic investment marks a major milestone in Agilent’s global journey, highlighting strong focus on India as a high-growth, innovation-driven market.
Global Pharma | 09/05/2025 | By Manvi | 264
Refeyn Installs 500th Mass Photometry System, Marking Major Milestone in Bioanalytics
Refeyn, the company behind pioneering mass photometry technology, has announced the installation of the 500th system based on its novel single-particle bioanalytical technology – notably, within just seven years of its spin out from Oxford University in 2018.
Global Pharma | 09/05/2025 | By Manvi | 278
India Pharma Market Grows 7.8 Percent in April: Report
The India Ratings and Research report shows that therapies such as cardiac, gastrointestinal, anti-diabetic, and dermatology received higher volume growth in April.
Global Pharma | 09/05/2025 | By Manvi | 317
Senores Pharmaceuticals Acquires ANDA for Tramadol Tablets from APDM Pharmaceuticals
Senores Pharmaceuticals has acquired the USFDA-approved ANDA for Tramadol Tablets from APDM Pharmaceuticals, using IPO proceeds to strengthen its pain management portfolio in the US market.
Global Pharma | 09/05/2025 | By Manvi | 808
Remlife Global, a Singapore-based subsidiary of Remedium Lifecare, has partnered with JiyaYu Lifesciences to replace animal-origin inputs in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates with proprietary fermentation and biocatalyst-based alternatives.
Global Pharma | 09/05/2025 | By Manvi | 297
Suven Pharmaceuticals Rebranded as Cohance Lifesciences
Suven Pharmaceuticals has renamed the company as Cohance Lifesciences with the objective to have a better reach worldwide.
Global Pharma | 08/05/2025 | By Manvi | 1278
Celerion Introduces Enhanced Version of Labnotes Bioanalytical Data Management Software
Celerion has launched an enhanced version of Labnotes, its electronic laboratory notebook software, introducing advanced data management, security, and reporting features to improve operational efficiency and support sponsor success.
Global Pharma | 08/05/2025 | By Manvi | 259
US FDA Appoints Dr. Vinay Prasad to Lead Biologics, Vaccines Division
US FDA selects Dr. Vinay Prasad as the head of the vaccine division of Biologics. The FDA expressed hope that his presence would bring more scrutiny and requirements to developers creating new gene therapies.
Global Pharma | 08/05/2025 | By Manvi | 324
US President Announces High Tariff Rates on Pharmaceutical Imports
America proposes high tariffs on pharmaceutical imports to boost domestic manufacturers.
Global Pharma | 08/05/2025 | By Manvi | 331
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy